VIVUS, Inc., a specialty pharmaceutical company committed to the development and commercialization of innovative therapies focusing on treatments for patients with serious unmet medical needs, reported financial results for the quarter ended September 30, 2019 and provided a business update.
November 5, 2019
· 20 min read